Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial von Diamant, Michaela, Prof, Van Gaal, Luc, Prof, Guerci, Bruno, Prof, Stranks, Stephen, MD, Han, Jenny, MS, Malloy, Jaret, PhD, Boardman, Marilyn K, PharmD, Trautmann, Michael E, Dr

Volltext

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes von Linnebjerg, Helle, Park, Soomin, Kothare, Prajakti A., Trautmann, Michael E., Mace, Kenneth, Fineman, Mark, Wilding, Ian, Nauck, Michael, Horowitz, Michael

Volltext

Psychological Treatment of Recurrent Headache in Children and Adolescents - A Meta-Analysis von Trautmann, E, Lackschewitz, H, Kröner-Herwig, B

Volltext

Genetic Diversity in Successive Age Cohorts of Ilex paraguariensis in Southern Brazil von Bittencourt, Larissa, e Silva, Douglas Trautmann, Nascimento, Bruno, Saiki, Flavia Anan, Stedille, Lilian Iara Bet, da Costa, Newton Clóvis Freitas, Mantovani, Adelar

Volltext

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinationa... von Barnett, Anthony H., MD, Burger, Jude, MS, Johns, Don, PhD, Brodows, Robert, MD, Kendall, David M., MD, Roberts, Anthony, MD, Trautmann, Michael E., MD

Volltext

Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment von Fineman, M. S., Mace, K. F., Diamant, M., Darsow, T., Cirincione, B. B., Booker Porter, T. K., Kinninger, L. A., Trautmann, M. E.

Volltext

Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-Level Data von Trautmann, Michael E., MD, Han, Jenny, MS, Ruggles, James, PhD

Volltext

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline von Pratley, Richard E, Jacob, Stephan, Baek, Seungjae, Trautmann, Michael E, Hompesch, Marcus, Han, OakPil, Stewart, John, Sorli, Christopher H, Shaunik, Alka, Yoon, Kun-Ho

Volltext

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study von Hompesch, Marcus, Kang, Jahoon, Han, OakPil, Trautmann, Michael E, Sorli, Christopher H, Ogbaa, Ike, Stewart, John, Morrow, Linda

Volltext

Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification von Trautmann, M. E., Vora, J.

Volltext

Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide von Rosenstock, Julio, Sorli, Christopher H, Trautmann, Michael E, Morales, Cristóbal, Wendisch, Ulrich, Dailey, George, Hompesch, Marcus, Choi, In Young, Kang, Jahoon, Stewart, John, Yoon, Kun-Ho

Volltext

Five-Year Efficacy and Safety Data of Exenatide Once Weekly von Wysham, Carol H., MD, MacConell, Leigh A., PhD, Maggs, David G., MD, Zhou, Ming, PhD, Griffin, Peter S., BA, Trautmann, Michael E., MD

Volltext

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years von Norwood, Paul, MD, FACP, Liutkus, Joanne F., MSW, MD, FRCP, Haber, Harry, MPH, Pintilei, Ella, MD, Boardman, Marilyn K., PharmD, Trautmann, Michael E., MD

Volltext

Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study von Del Prato, Stefano, Kang, Jahoon, Trautmann, Michael E., Stewart, John, Sorli, Christopher H., Derwahl, Michael, Soto, Alfonso, Yoon, Kun‐Ho

Volltext

Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes von Yoon, Kun‐Ho, Kang, Jahoon, Kwon, Se Chang, Trautmann, Michael E., Hompesch, Marcus, Stewart, John, Sorli, Christopher H.

Volltext

Autonomous GPR Surveys using the Polar Rover Yeti von Lever, J. H., Delaney, A. J., Ray, L. E, Trautmann, E., Barna, L. A., Burzynski, A. M

Volltext

REM sleep behavioral events (RBE): a new marker for neurodegeneration in early parkinson’s disease? von Sixel-Döring, F, Trautmann, E, Mollenhauer, B, Trenkwalder, C

Volltext

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours von Arnold, R, Trautmann, M E, Creutzfeldt, W, Benning, R, Benning, M, Neuhaus, C, Jürgensen, R, Stein, K, Schäfer, H, Bruns, C, Dennler, H J

Volltext

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study von Pratley, Richard E., Kang, Jahoon, Trautmann, Michael E., Hompesch, Marcus, Han, OakPil, Stewart, John, Sorli, Christopher H., Jacob, Stephan, Yoon, Kun‐Ho

Volltext

Associated factors for REM sleep behavior disorder in Parkinson disease von SIXEL-DÖRING, Friederike, TRAUTMANN, Ellen, MOLLENHAUER, Brit, TRENKWALDER, Claudia

Volltext